Lisa Brockway

How to Address Barriers to Clinical Trial Patient Recruitment [Update]

[Updated June 2019] Read more

Webinar Recap: Precision Recruitment

With clinical trial protocols becoming ever more complex, it can feel like it’s never been more difficult to find patients who are both eligible for and interested in a particular clinical trial. Traditional methods of recruitment are becoming less impactful, which is why it’s time to consider a new approach: precision recruitment. Read more

The Next Phase of Faster Clinical Trial Patient Recruitment

For years, clinical trial patient recruitment has looked the same: identify eligibility criteria for a single trial, conduct traditional media outreach, screen patients for that trial, and hope for the best. Increasingly, however, sponsors have been turning to technology, getting more specific in their outreach and therefore becoming more successful in their recruiting not just for one trial, but ... Read more

5 Benefits of Faster Clinical Trial Patient Recruitment

One of the most frustrating elements of medical research today is the speed — patients need new treatments now, but often, clinical trials are delayed or closed due to difficulty finding patients to take part. With clinical trial patient recruitment, sponsors can not only meet deadlines, but beat them, bringing new treatments to patients faster. Here, we break down the key reasons to set your ... Read more

How Access to Health Data Drives Patient Empowerment: A Recap of FasterCure’s Recent Webinar

Last week, we had the pleasure of listening in to an important webinar hosted by FasterCures called “The Game-Changing Impact of Empowering Patients with Health Data.” Moderated by FasterCures’ Executive Director, Tanisha Carino, the online panel discussed the importance of patient access to health data, while walking through potential privacy concerns and other pitfalls that accompany access. On ... Read more

Clinical Trial Patient Recruitment Case Study: Alzheimer's Disease

Clinical trial patient recruitment can be difficult for Alzheimer's disease trials, particularly for prodromal Alzheimer's. Increasingly, sponsors are turning to Alzheimer's patient registries for help. Here, we'll share an Alzheimer's registry recruitment case study that demonstrates the need for community engagement and precision matching for these types of projects. Read more

Glimpsing a World Without Clinical Trials

While you’re at the pharmacy picking up a medication you’ve been prescribed, you might not be thinking about all of the research that went into making that treatment available to you. On average, it takes at least ten years for a new medicine to make it to market, and six to seven of those years involve clinical trials. It’s important to understand all that goes into developing drugs, so that you ... Read more

BIO Recap: Bridging the Gap Between Industry and Advocacy

BIO International Conference happened earlier this month in Boston. Antidote was there among more than 45,000 attendees to network, share ideas, learn new technologies, and be inspired. It’s a conference that fosters collaboration between top industry players and advocacy organizations alike, on a massive scale. Read more

From Research Studies to Your Pharmacy Shelves: The Drug Development Process

When you’re feeling sick and your doctor prescribes you medication, you’re likely not thinking about everything that happened before that drug got into your hands. But the fact is that on average, it takes at least ten years for a new medicine to make it to market — from initial discovery to your local pharmacy. Of those ten years of drug development, the treatment is making its way through ... Read more

Relentless Health Value Podcast: How Being Patient-Centric, Not Trial-Centric, Can Improve Clinical Trial Recruitment and Retention

The clinical trial landscape is shifting — but is it enough? Antidote’s Founder, Pablo Graiver, was recently interviewed for the Relentless Health Value podcast to discuss this fundamental question. Read more

Topics: Podcast